The inhibitive effect of the pancreatic cancer cells mediating by shRNA targeting APRIL gene

( views:280, downloads:0 )
WANG Feng(Department of Clinical Laboratory, Third People's Hospital of Nantong City, Nantong University, Nantong 226001, China)
CHEN Lin()
SHAO Jian-guo()
MAO Zhen-biao()
Journal Title:
Volume 8, Issue 03, 2008
Key Word:
Pancreatic neoplasms;RNA interference;Lentivirus;APRIL

Abstract: Objective To investigate the inhibitive effect of shRNA (short hairpin RNA) targeting APRIL gene on the pancreatic cancer cells in vitro and in vivo, in order to explore the feasibility of gene therapy for pancreatic cancer. Methods The LV-shAPRIL targeting APRIL gene had been constructed before, and was used to infect the CFPAC-1 cells. Cell proliferation and apoptosis were examined by MTT and flow cytometry. Then CFPAC-1 cells were used to construct the model of transplantation tumor into the nude mice, the tumor growth was assessed after LV-shAPRIL treatment. Results 96 hours after the LV-shAPRIL infection into CFPAC-1 cells, the cell proliferation was significantly inhibited when compared with control group and lentivirus infection group (P<0.05 ). Flow cytometry showed the apoptosis ratio of the CFPAC-1 cells was (17.35±0.96)% in LV-shAPRIL group, which was higher than that in control group and lentivirus infection group (P<0.05 ). After LV-shAPRIL injection into the model of nude mice, the tumor growth was slower than that in the two control groups. The tumor's volume of the LV-shAPRIL group was(821.8±123.3) mm3 and the mass was (2.16±0.18)g at 27 day, and were obviously depressed, when compared with two control groups (P±0.05). Conclusions LV-shAPRIL targeting APRIL gene can inhibit the growth of the CFPAC-1 cells in vitro and vivo. This may provide a new gene therapy approach for pancreatic cancer.

  • [1]Hahne M,Kataoka T,Schroter M,et al.APRIL,a new ligand of the tumor necrosis factor family,stimulates tumor cell growth.J Exp Med,1998,188:1185-1190.
  • [2]Kelly K,Manos E,Jensen G,et al.APRIL/TRDL-1,a tumor necrosis factor-like ligand,stimulates cell death.Cancer Res,2000,60:1021-1027.
  • [3]陈琳,王峰,邵建国,等.胰腺癌CFPAC1细胞增殖诱导配体基因shRNA慢病毒表达载体的构建.中华胰腺病杂志,2008,8:88-91.
  • [4]Chiu A,Xu W,He B,et al.Hodgkin lymphoma cells express TCAI and BCMA receptors and generate surviral and proliferation signals in response to BAFF and APRIL.Blood,2007,109:729-739.
  • [5]王唯一,毛振彪,潘正平,等.人胰腺癌组织中增殖诱导配体蛋白的表达及意义.第二军医大学学报,2007,2:214-215.
  • [6]邵建国,毛振彪,谭畅,等.消化系肿瘤增殖诱导配体高表达细胞株的筛选.胰腺病学,2006,5:289-291.
  • [7]Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
  • [8]Jazag A,Ijichi H,Kanai F,et al.Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expres-sion profiles induced by transforming growth factor-β.Oncogene,2005,24:662-671.
  • [9]Romano G.Current development of adeno-associated viral vectors.Drng News Perspect,2005,18:128-134.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615